gastric emptying glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. receptor agonists and GLP-1 and glucose-dependent insulinotropic Effects of the once-daily GLP-1

First, postmenopausal women represent a unique population in which hormonal changes exacerbate both RA symptoms and metabolic dysfunction 14

Gastrointestinal tract is home to microbiota, which mutually interact with the host to modulate gut physiology and extraintestinal functions

Take home points: Empagliflozin has a large study that shows a small but significant reduction in death and heart failure hospitalizations (NNT for primary outcome = 63 patients for ~3 years) compared to placebo in patients with diabetes and CV disease Empagliflozin can cause urinary and genital infections and ketoacidosis with near normal glucose Because of its mechanism (spilling glucose through the urine), it may develop a role in diabetes mellitus type 1 Refrences: American Diabetes Association: Standards of medical care in diabetes - 2016

PV is generated via retail sales and a LifeVantage promoters own orders

Fitness1.bg 43.46 / 85, ,